Yes it is interesting...I am eagerly waiting to hear back
NextGENe demo talk was impressive - they have a way to somewhat assemble the reads and use the longer contigs to align to reference - irons out errors
CLC video was interesting as well .. but click click interface! how well does it work for core labs?
Unconfigured Ad
Collapse
X
-
CLC Genomics Workbench released
I just heard from the CLC Bio sales rep that the Genomics Workbench has been released.
Welcome to QIAGEN Digital Insights LabCorp uses QCI and HGMD to improve identification and interpretation of genetic variants within inhereited diseases.Read...
This page has links to their user manuals - which look good. If they do what they say on the box, then I can imagine lots of people would be happy to pay up a bit even though it is not a published/open-source system.
I've asked for an evaluation copy and will post a review over here for everyone if I get it soon.
- Sujai
Leave a comment:
-
Hybrid yes, but not de-novo of Solexa at the moment.Originally posted by Torst View PostThe recent version of MIRA claims to be able to perform a true hybrid assembly of sequences from Sanger, 454-FLX, and Illumina. We are still assessing it. See http://chevreux.org/projects_mira.html
Leave a comment:
-
The recent version of MIRA claims to be able to perform a true hybrid assembly of sequences from Sanger, 454-FLX, and Illumina. We are still assessing it. See http://chevreux.org/projects_mira.html
Leave a comment:
-
Yes, I'm waiting for that too... I hope it's as good as they're saying it will be. The initial release is supposedly able to do de novo assemblies on all sanger, illumina and 454 data, which would be nice.
Leave a comment:
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
38 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
44 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Leave a comment: